136 related articles for article (PubMed ID: 25254176)
1. Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis.
Borgerding MP; Absher RK; So TY
World J Clin Pediatr; 2013 Nov; 2(4):65-9. PubMed ID: 25254176
[TBL] [Abstract][Full Text] [Related]
2. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
[TBL] [Abstract][Full Text] [Related]
4. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.
Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L
Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184
[TBL] [Abstract][Full Text] [Related]
6. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
7. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
Russo K; Chhunchha P
J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):116-122. PubMed ID: 36701332
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Individualized Pain Plans for Children With Sickle Cell Disease Admitted for Vaso-occlusive Crisis at Riley Hospital for Children.
Arends AM; Perez A; Wilder C; Jacob SA
J Pediatr Pharmacol Ther; 2022; 27(4):312-315. PubMed ID: 35558343
[TBL] [Abstract][Full Text] [Related]
9. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the acute sickle cell vaso-occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine.
Campos J; Lobo C; Queiroz AM; do Nascimento EM; Lima CB; Cardoso G; Ballas SK
Eur J Haematol; 2014 Jul; 93(1):34-40. PubMed ID: 24571671
[TBL] [Abstract][Full Text] [Related]
12. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
13. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravenous patient-controlled analgesia with tramadol versus morphine after microvascular breast reconstruction.
Silvasti M; Svartling N; Pitkänen M; Rosenberg PH
Eur J Anaesthesiol; 2000 Jul; 17(7):448-55. PubMed ID: 10964147
[TBL] [Abstract][Full Text] [Related]
15. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
16. Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients.
Al-Anazi A; Al-Swaidan L; Al-Ammari M; Al-Debasi T; Alkatheri AM; Al-Harbi S; Obaidat AA; Al-Bekairy AM
Saudi J Anaesth; 2017; 11(4):437-441. PubMed ID: 29033725
[TBL] [Abstract][Full Text] [Related]
17. Does patient-controlled analgesia achieve better control of pain and fewer adverse effects than intramuscular analgesia? A prospective randomized trial.
Nitschke LF; Schlösser CT; Berg RL; Selthafner JV; Wengert TJ; Avecilla CS
Arch Surg; 1996 Apr; 131(4):417-23. PubMed ID: 8615729
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis.
Rector K; Merchant S; Crawford R; Arnall JR; Symanowski J; Veeramreddy P; Osunkwo I
Hosp Pharm; 2021 Dec; 56(6):725-728. PubMed ID: 34732930
[No Abstract] [Full Text] [Related]
19. Is single-shot epidural analgesia more effective than morphine patient-controlled analgesia for donor nephrectomy?
Milan Z; Das S; Kocarev M; Rawari V
Transplant Proc; 2011 Dec; 43(10):3588-92. PubMed ID: 22172810
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Vaso-occlusive Crisis Management With Patient-Controlled Analgesia in Children With Sickle Cell Disease Requiring Hospitalization.
Arbitre C; Pastore Y; Bailey B; Kleiber N; Robitaille N; Villeneuve E; Viau A; Bergeron MJ; Trottier ED
J Pediatr Pharmacol Ther; 2021; 26(6):615-623. PubMed ID: 34421412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
